neostigmine has been researched along with Convergent Strabismus in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Excerpt | Relevance | Reference |
---|---|---|
"A 70-year-old man with known vascular disease, who had bilateral internuclear ophthalmoplegia, and an 18-month-old girl with a long-term variable esotropia culminating in a postinfectious oculopharyngeal neuropathy both responded with a positive edrophonium chloride (Tensilon) test, strongly suggesting the diagnosis of myasthenia gravis." | 3.66 | Ocular myasthenia gravis mimicking pseudointernuclear ophthalmoplegia and variable esotropia. ( Acers, TE, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acers, TE | 1 |
1 other study available for neostigmine and Convergent Strabismus
Article | Year |
---|---|
Ocular myasthenia gravis mimicking pseudointernuclear ophthalmoplegia and variable esotropia.
Topics: Aged; Diagnosis, Differential; Edrophonium; Esotropia; Female; Humans; Infant; Male; Myasthenia Grav | 1979 |